Jake R. Morgan, PhD
Research Assistant Professor
Boston University School of Public Health
Dept of Health Law, Policy & Management

PhD, Boston University
MS, Montana State University




I am a health services researcher dedicated to using real world data to predict individual- and population-level health outcomes and inform health policy. My postdoctoral research experience at a large safety net hospital has exposed me to the challenges to, and the urgency of, addressing the opioid crisis, and I productively research questions of addiction and infectious disease by leveraging real world data, simulation modeling, and innovative methodology. I am most interested in answering important scientific questions with immediate policy and practice relevance; as such, I work closely with the Massachusetts Department of Public Health and the NIDA-sponsored Center for Health Economics of Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) and stakeholders from policy and research backgrounds on these important questions.

2016 Patient-Centered Outcomes Research Institute (PCORI): Trainee Scholarship
2015 Lee Lusted Prize winner


The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial
01/01/2019 - 12/31/2022 (Subcontract PI)
Denver Health Medical Center NIH NIDA
5R01DA042982-03

IMPROVING NALOXONE ACCESS AND ITS EFFECTS ON DRUG ABUSE AND OVERDOSES
02/25/2019 - 09/29/2021 (Subcontract PI)
RAND Corporation HHS CDC
5R01CE002999-02

Expanding FDA's Opioids Systems Model to Enable Economic Evaluations and Outcome Analyses of National Opioid Policies
09/01/2020 - 08/31/2021 (Subcontract PI)
General Hospital Corp d/b/a Massachusetts General Hospital HHS FDA
1U01FD007064-01

Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Evaluating Intervention Outcomes for Individuals, Systems, and Communities
07/15/2020 - 04/30/2021 (Subcontract PI)
Weill Medical College of Cornell University NIH NIDA
2P30DA040500-06A1

Researching Effective Strategies to Prevent Opioid Death (RESPOND)
04/01/2019 - 03/31/2021 (Subcontract PI)
Boston Medical Center Corporation NIH NIDA
5R01DA046527-03

Impact of health insurance type and transitions on treatment for opioid use disorder
04/01/2019 - 03/31/2021 (Subcontract PI)
Boston Medical Center Corporation Robert Wood Johnson


Prevention and Rescue Of Fentanyl and Other Opioid Overdoses Using Optimized Naloxone Distribution Strategies (PROFOUND)
05/15/2019 - 02/28/2021 (Subcontract PI)
Weill Medical College of Cornell NIH NIDA
5U01DA047408-02

Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (CHERISH Supplement)
05/01/2019 - 07/15/2020 (Subcontract PI)
Weill Medical College of Cornell NIH NIDA
3P30DA040500-05S1

WHO Level of Detection
04/01/2019 - 06/30/2020 (Subcontract PI)
FIND Foundation World Health Org


Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care (CHERISH)
05/01/2019 - 04/30/2020 (Subcontract PI)
Weill Medical College of Cornell University NIH NIDA
5P30DA040500-05



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Morgan JR, Barocas JA, Murphy SM, Epstein RL, Stein MD, Schackman BR, Walley AY, Linas BP. Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting. JAMA Netw Open. 2020 12 01; 3(12):e2029676.View Related Profiles. PMID: 33320266
     
  2. Bronico JVR, Matthews BJ, Perkins RB, Lee EM, Morgan JR, Nitschmann CC, Paasche-Orlow MK. Incidence of Gynecologic Cancers in Women after Uterine Artery Embolization. J Minim Invasive Gynecol. 2020 Oct 25.View Related Profiles. PMID: 33115685
     
  3. Aldridge AP, Barbosa C, Barocas JA, Bush JL, Chhatwal J, Harlow KJ, Hyder A, Linas BP, McCollister KE, Morgan JR, Murphy SM, Savitzky C, Schackman BR, Seiber EE, E Starbird L, Villani J, Zarkin GA. Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study. Drug Alcohol Depend. 2020 Dec 01; 217:108336.View Related Profiles. PMID: 33152672
     
  4. Gutkind S, Schackman BR, Morgan JR, Leff JA, Agyemang L, Murphy SM, Akiyama MJ, Norton BL, Litwin AH, Linas BP. Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs. Clin Infect Dis. 2020 03 17; 70(7):1397-1405.View Related Profiles. PMID: 31095683
     
  5. Morgan JR, Wang J, Barocas JA, Jaeger JL, Durham NN, Babakhanlou-Chase H, Bharel M, Walley AY, Linas BP. Opioid overdose and inpatient care for substance use disorder care in Massachusetts. J Subst Abuse Treat. 2020 05; 112:42-48.View Related Profiles. PMID: 32199545
     
  6. Carey K, Morgan JR. Payments for outpatient joint replacement surgery: A comparison of hospital outpatient departments and ambulatory surgery centers. Health Serv Res. 2020 04; 55(2):218-223.View Related Profiles. PMID: 31971261
     
  7. Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes Associated with Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis. Clin Infect Dis. 2020 Jan 21.View Related Profiles. PMID: 31960025
     
  8. Carey K, Morgan JR, Lin MY, Kain MS, Creevy WR. Patient Outcomes Following Total Joint Replacement Surgery: A Comparison of Hospitals and Ambulatory Surgery Centers. J Arthroplasty. 2020 01; 35(1):7-11.View Related Profiles. PMID: 31526700
     
  9. Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BP. Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. Int J Drug Policy. 2019 10; 72:160-168.View Related Profiles. PMID: 31085063
     
  10. Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug Alcohol Depend. 2019 07 01; 200:34-39.View Related Profiles. PMID: 31082666
     
Showing 10 of 32 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 32 publications over 7 distinct years, with a maximum of 7 publications in 2020

YearPublications
20141
20156
20164
20173
20185
20196
20207


Recent (within 3 months)

Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study.

Physician's Weekly 11/9/2020
Contact for Mentoring:

617.358.2960
Download vCard

Morgan's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (154) concept(s)
_
Media Mentions
_
Co-Authors
See all (32) people
_
Similar People
See all (60) people
_
Same Department
Search Department